Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Katalysen Ventures is a Swedish venture developer and investment firm that operates as a "venture builder" for early-stage B2B software and technology companies. The firm provides a combination of hands-on expertise and capital to help reduce risk and accelerate growth for its portfolio companies. While not a dedicated life sciences company, Katalysen Ventures has invested in health-tech and med-tech startups as part of its broader technology focus. The company is publicly traded and focuses on bridging the gap between early-stage entrepreneurship and institutional capital. Its business model involves taking equity stakes in exchange for strategic development services and direct investment.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Katalysen Ventures.